Liberty Science Center recognized three scientists whose work spans artificial intelligence, drug repurposing and species ...
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced at the 2026 BIO-IT World Conference & Expo in Boston that the ...
Researchers developing autonomous artificial intelligence research tools say that they’ll soon be able to integrate with lab ...
Pharmaceutical Technology on MSN
QIAGEN and NVIDIA partner on AI drug discovery
The integration helps researchers understand disease biology and uncover biomarkers for developing new medicines.
Cyprus Mail on MSN
AI joins the quest to find new treatments for rare diseases
Rare neuromuscular diseases often lack treatments because developing targeted drugs is slow, costly and risky for companies. A new approach using AI and stem cell models could finally shift the ...
Food Allergy Fund Debuts Caregiver resource with Dr. Becky Kennedy, alongside breakthroughs in food allergy detection and treatment The Food Allergy Fund (FAF) today convened scientists, investors, ...
A formal FDA call for repurposing nominations prioritizes areas where unmet need is high and manufacturer incentives to pursue supplemental approvals are limited. Submissions may be grounded in ...
The FDA is seeking public input on drug repurposing efforts aimed at expanding treatment options for diseases tied to unmet medical needs. The agency said identifying new uses for FDA-approved drugs ...
The US Food and Drug Administration (FDA) is asking for input on repurposing older drugs for new therapeutic uses to address unmet medical needs across a wide range of therapeutic areas. FDA said that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results